Rahmani, F; Asgharzadeh, F; Avan, A; Barneh, F; Parizadeh, MR; Ferns, GA; Ryzhikov, M; Ahmadian, MR; Giovannetti, E; Jafari, M; Khazaei, M; Hassanian, SM
Rigosertib potently protects against colitis-associated intestinal fibrosis and inflammation by regulating PI3K/AKT and NF-?B signaling pathways. (2020), Life Sci, 249, 117470.